Back to top
more

Molina Healthcare (MOH)

(Delayed Data from NYSE)

$190.71 USD

190.71
1,472,768

+8.15 (4.46%)

Updated Sep 24, 2025 04:00 PM ET

After-Market: $190.71 0.00 (0.00%) 7:16 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.64%
2Buy17.83%
3Hold9.69%
4Sell5.29%
5Strong Sell2.54%
S&P50011.29%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

5-Strong Sell of 5         5

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value F Growth F Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 5% (234 out of 246)

Industry: Medical - HMOs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Molina (MOH) Loses 18.3% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

by Zacks Equity Research

The heavy selling pressure might have exhausted for Molina (MOH) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

Sumit Singh headshot

4 Top Stocks With Strong Interest Coverage for the Second Half of 2025

by Sumit Singh

Strong interest coverage ratios make HBM, STRL, MOH, and VRT standout picks for navigating debt and driving earnings growth.

Zacks Equity Research

Zacks Industry Outlook Highlights Cigna, Humana, Centene and Molina Healthcare

by Zacks Equity Research

CNC, MOH, CI, and HUM are set to benefit from Medicare demand, steady premiums, and tech-driven growth in the HMO space.

Debasmita Chatterjee headshot

4 HMO Stocks Set to Thrive From Steady Premium Flows, M&A Strategy

by Debasmita Chatterjee

Rising premiums, ongoing technological innovation and the growing demand for Medicare plans are anticipated to propel the performance of the Zacks Medical-HMO industry players. CI, HUM, CNC and MOH are poised to benefit from favorable industry prospects.

Zacks Equity Research

Here's Why MOH Shares Are Attracting Prudent Investors Now

by Zacks Equity Research

Molina Healthcare draws investor interest with strong earnings growth, contract wins and premium revenue momentum despite rising costs.

Zacks Equity Research

Is Molina Healthcare (MOH) a Great Value Stock Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Sumit Singh headshot

Bet on These 4 Stocks With Exciting Interest Coverage Ratio

by Sumit Singh

URBN, STRL, MOH and CNC show strong interest coverage ratios, signaling solid debt management and earnings strength.

Zacks Equity Research

Bears are Losing Control Over Molina (MOH), Here's Why It's a 'Buy' Now

by Zacks Equity Research

Molina (MOH) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.

Zacks Equity Research

Should Value Investors Buy Molina Healthcare (MOH) Stock?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Equity Research

Zacks.com featured highlights Sterling Infrastructure, BJ's Wholesale, Molina Healthcare and Halozyme

by Zacks Equity Research

Sterling, BJ's, Molina, and Halozyme stand tall with robust earnings growth and high interest coverage in June picks.

Sumit Singh headshot

4 Stocks With Strong Interest Coverage Ratios to Buy in June 2025

by Sumit Singh

STRL, BJ, MOH, and HALO shine with strong interest coverage ratios, signaling solid fundamentals for June 2025.

Zacks Equity Research

Molina (MOH) Down 1.3% Since Last Earnings Report: Can It Rebound?

by Zacks Equity Research

Molina (MOH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

The Zacks Analyst Blog Highlights UnitedHealth, Centene and Molina Healthcare

by Zacks Equity Research

UnitedHealth, Centene and Molina Healthcare are part of the Zacks top Analyst Blog.

Tirthankar Chakraborty headshot

This Is Why UnitedHealth Stock Bounced Back, But Is Better to Avoid

by Tirthankar Chakraborty

Does UnitedHealth's Insiders scooping up shares of UNH justify a buy decision today? Let's explore -

Zacks Equity Research

Zacks.com featured highlights Sterling Infrastructure, AXIS Capital, Molina Healthcare and Halozyme

by Zacks Equity Research

Sterling Infrastructure, AXIS Capital, Molina Healthcare and Halozyme have been highlighted in this Screen of The Week article.

Sumit Singh headshot

4 Stocks With Impressive Interest Coverage Ratio to Buy Now

by Sumit Singh

STRL, AXS, MOH & HALO's impressive interest coverage ratios highlight that these companies can withstand financial hardships.

Zacks Equity Research

Are Investors Undervaluing Molina Healthcare (MOH) Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Equity Research

Centene Q1 Earnings Beat Estimates on Marketplace Business Strength

by Zacks Equity Research

CNC's Q1 results benefit from improved premiums as a result of a strong PDP business, partly offset by elevated operating costs. It currently expects 2025 premium and service revenues within $164-$166 billion.

Zacks Equity Research

Molina Healthcare Q1 Earnings Beat Estimates on Growing Premiums

by Zacks Equity Research

MOH continues to expect 2025 premium revenues to be around $42 billion.

Zacks Equity Research

Here's What Key Metrics Tell Us About Molina (MOH) Q1 Earnings

by Zacks Equity Research

Although the revenue and EPS for Molina (MOH) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Zacks Equity Research

Molina (MOH) Beats Q1 Earnings and Revenue Estimates

by Zacks Equity Research

Molina (MOH) delivered earnings and revenue surprises of 3.75% and 0.24%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Molina Healthcare to Report Q1 Earnings: Key Estimates to Watch

by Zacks Equity Research

MOH's first-quarter earnings are likely to have benefited from growing premiums, partially offset by higher expenses.

Zacks Equity Research

Insights Into Molina (MOH) Q1: Wall Street Projections for Key Metrics

by Zacks Equity Research

Evaluate the expected performance of Molina (MOH) for the quarter ended March 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

Zacks Equity Research

Centene (CNC) Reports Next Week: Wall Street Expects Earnings Growth

by Zacks Equity Research

Centene (CNC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Molina (MOH) Reports Next Week: Wall Street Expects Earnings Growth

by Zacks Equity Research

Molina (MOH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.